Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOT

Biotech Acquisition (BIOT) Stock Price, News & Analysis

Biotech Acquisition logo

About Biotech Acquisition Stock (NASDAQ:BIOT)

Advanced Chart

Key Stats

Today's Range
$10.14
$10.19
50-Day Range
$10.08
$10.32
52-Week Range
$8.30
$10.41
Volume
44,400 shs
Average Volume
244,605 shs
Market Capitalization
$291.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Receive BIOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOT Stock News Headlines

Israel-Iran WAR Could Destroy Trump's Presidency
The missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't have happened at a worse time. Trump is already dealing with Biden's $34 trillion debt bomb AND now a Middle East war. This is exactly what the "resistance" has been waiting for.
See More Headlines

BIOT Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotech Acquisition investors own include (AOL) (AOL), CNX Resources (CNX), Southwest Airlines (LUV), Meta Platforms (META), Tesla (TSLA), Finance of America Companies (FOA) and Equifax (EFX).

Company Calendar

Today
6/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOT
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.86 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.95) per share
Price / Book
-10.68

Miscellaneous

Free Float
23,288,000
Market Cap
$291.81 million
Optionable
Not Optionable
Beta
-0.12
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:BIOT) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners